Clinical Trial Update: Tissue Collection for Biomarkers Determining Resistance to Ibrutinib

View source ↗

Summary

Trial update on tissue collection for biomarkers to determine resistance to ibrutinib in mantle cell lymphoma and chronic lymphocytic leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Mantle Cell Lymphoma

Drugs mentioned

• Ibrutinib (ibrutinib)

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Mantle Cell Lymphoma, Chronic Lymphocytic Leukaemia | Status: UNKNOWN